Maozhen Gong

2PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 14, 2023
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Response.

Charu Aggarwal, Maozhen Gong, Rakesh Kumar

|Dec 01, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Charu Aggarwal, Nabil F Saba, Alain Algazi

Pageof 1